Studies Further Confirm That Actos Raises Risk Of Bladder Cancer

New studies conducted by two separate research groups have further established a connection between bladder cancer and the drug Actos. The link between Actos and cancer was first detected about 18 months ago. Follow-up studies have supported the initial findings and reveal that a disproportionate amount of Actos patients later develop bladder cancer.

A recent study by researchers at the University of Pennsylvania concludes that Actos may not be only diabetes medication responsible for bladder cancer. The authors believe that all diabetic drugs known as glitazones, or thiazolidinediones, present an increased risk of cancer. Popular glitazones include:

• Actos

• Avandia

• Rezulin

Studies indicate that both the dosage and period of time taking the medication factor into Actos patients' risk of bladder cancer. In other words, your chances of developing cancer are greater if you are on high doses of glitazones and/or use them for the long-term treatment of diabetes.

If you or a loved one has developed bladder cancer after taking Actos, Avandia or Rezulin, contact an experienced Michigan medication error lawyer.

McKeen & Associates proficiently assists victims of dangerous medications, including those seriously harmed by the side effects of diabetes drugs.

Source: AboutLawsuits.com, "Studies Confirm Link Between Actos And Bladder Cancer," June 1, 2012

No Comments

Leave a comment
Comment Information

Free Consultations | No Fee Unless We Win

Email us or call us at 866-585-1076 to discuss your medical malpractice case. There is no cost, no obligation and never a fee unless we are successful. You have nothing to lose by learning your rights and options today.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Request a Free Consult

Penobscot Building, 645 Griswold Street, Suite 4200
Detroit, MI 48226

Toll Free: 866-585-1076
Phone: 313-447-0634
Fax: 313-961-5985
Detroit Office Map

Ohio Office
315 East Main Street
Suite A
Ottawa, OH 45875

Phone: 269-220-3379
Ohio Office Map